Dual CHK1/CHK2 Inhibitors Synergize Against Neuroblastoma
Neuroblastoma, a devastating pediatric malignancy, remains one of the most challenging childhood cancers despite decades of therapeutic advancements. This extracranial ...
Tag: DNA damage response in cancer
DNA errors uncovered that enable tumor survival
In a groundbreaking study published in Molecular Cell, researchers at NYU Langone Health have uncovered a novel mechanism by which ...
HERC2: A Promising Biomarker in Ovarian Cancer
In the realm of oncology, identifying reliable biomarkers for disease prognosis and treatment response is crucial for personalized medicine. The ...
Boosting Tumor Control: Radiation and ATR Inhibitor Trial
In the relentless pursuit of more effective cancer therapies, a novel approach combining palliative irradiation with targeted molecular inhibition is ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!